NanoString Technologies Analysis: $108M Raised
What is NanoString Technologies?
Digital molecular barcoding for spatial transcriptomics and proteomics
Location
Seattle, United States
Employees
201-500
Founded
2003
Product Features & Capabilities
- GeoMx® Digital Spatial Profiler for spatial transcriptomics and proteomics
- CosMx™ Spatial Molecular Imager for high-plex single-cell imaging
- nCounter® Analysis System for gene expression profiling
- AtoMx® Spatial Informatics Platform for cloud-based spatial data analysis
Use Cases
Profile 570+ proteins and whole transcriptomes in FFPE tissue; Perform high-plex spatial transcriptomics with 1000-plex RNA panels; Analyze cellular interactions and biomarker discovery in archived tissue samples; Conduct single-cell spatial analysis with subcellular resolution; Generate organ atlases using spatial data from human tissues
Other Considerations
Acquired by Bruker Corporation in 2024; 7,000+ peer-reviewed publications; Used by Human Cell Atlas project; Validated in clinical trial samples with archival FFPE tissue; Supported by academic and research institutions globally
